Texas A&M Researchers To Further Develop Unique Cancer Drug With $2.3 Million NIH Grant

Preliminary data indicate that the compounds developed in the laboratory of Dr. Stephen Safe both kill tumors and rejuvenate the immune system, which becomes exhausted as it responds to cancer.